Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arteether
2. Arteether, (3r-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12ar*))-isomer
3. Arteether, (3r-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12beta,12ar*))-isomer
4. Artemotil
5. Artether
6. Beta-artether
7. Sm-227
1. Beta-artether
2. 109716-83-8
3. Chembl206947
4. Schembl4539927
5. Dtxsid501107226
6. Akos025401866
7. 131175-88-7
8. Ac-26457
9. (1r,4s,5r,8s,9r,12r,13r)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
10. (3r,12ar)-3,6alpha,9beta-trimethyl-10-ethoxy-3beta,12alpha-epoxy-3,4,5,5aalpha,6,7,8,8aalpha,9,10-decahydropyrano[4,3-j]-1,2-benzodioxepin
11. Rel-(3r,5as,6r,8as,9r,12r,12ar)-10-ethoxydecahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin
| Molecular Weight | 312.4 g/mol |
|---|---|
| Molecular Formula | C17H28O5 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 312.19367399 g/mol |
| Monoisotopic Mass | 312.19367399 g/mol |
| Topological Polar Surface Area | 46.2 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 443 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Schistosomicides
Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)
Amebicides
Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)
ABOUT THIS PAGE
46
PharmaCompass offers a list of AC1Q6ZLJ API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AC1Q6ZLJ manufacturer or AC1Q6ZLJ supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AC1Q6ZLJ manufacturer or AC1Q6ZLJ supplier.
PharmaCompass also assists you with knowing the AC1Q6ZLJ API Price utilized in the formulation of products. AC1Q6ZLJ API Price is not always fixed or binding as the AC1Q6ZLJ Price is obtained through a variety of data sources. The AC1Q6ZLJ Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AC1Q6ZLJ manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AC1Q6ZLJ, including repackagers and relabelers. The FDA regulates AC1Q6ZLJ manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AC1Q6ZLJ API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AC1Q6ZLJ supplier is an individual or a company that provides AC1Q6ZLJ active pharmaceutical ingredient (API) or AC1Q6ZLJ finished formulations upon request. The AC1Q6ZLJ suppliers may include AC1Q6ZLJ API manufacturers, exporters, distributors and traders.
AC1Q6ZLJ Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AC1Q6ZLJ GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AC1Q6ZLJ GMP manufacturer or AC1Q6ZLJ GMP API supplier for your needs.
A AC1Q6ZLJ CoA (Certificate of Analysis) is a formal document that attests to AC1Q6ZLJ's compliance with AC1Q6ZLJ specifications and serves as a tool for batch-level quality control.
AC1Q6ZLJ CoA mostly includes findings from lab analyses of a specific batch. For each AC1Q6ZLJ CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AC1Q6ZLJ may be tested according to a variety of international standards, such as European Pharmacopoeia (AC1Q6ZLJ EP), AC1Q6ZLJ JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AC1Q6ZLJ USP).
